| ANNA-1 | Antineuronal nuclear antibody type 1 |
| ANNA-2 | Antineuronal nuclear antibody type 2 |
| BCVA | Best-corrected visual acuity |
| CAII | Carbonic anhydrase II |
| CAR | Cancer-associated retinopathy |
| CRMP5 | Collapsin response mediator protein 5 |
| CSF | Cerebrospinal fluid |
| DNER | Delta/Notch-like epidermal growth factor-related receptor |
| ffERG | Full-field electroretinogram |
| IRD | Inherited retinal dystrophy |
| IVIG | Intravenous immunoglobulin |
| KLHL11 | Kelch-like protein 11 |
| MAP1B | Microtubule-associated protein 1B |
| MAR | Melanoma-associated retinopathy |
| mfERG | Multifocal electroretinogram |
| mGluR1 | Metabotropic glutamate receptor 1 |
| MRI | Magnetic resonance imaging |
| OCT | Optical coherence tomography |
| PCA-1 | Purkinje cell cytoplasmic antibody type 1 |
| PCD | Paraneoplastic cerebellar degeneration |
| RPE | Retinal pigment epithelium |
| VGCC | Voltage-gated calcium channel |